Agfa HealthCare, a leading provider of diagnostic imaging and healthcare IT solutions, announces today that it has signed over 150 agreements for its leading healthcare IT solutions during the first 8 months of the year. Systems sold include the company’s leading Picture Archiving and Communication System (PACS) called IMPAX, and its associated Radiology Information System (RIS) and Nuclear Information System (NIS), IMPAX Cardiovascular, IMPAX Data Center, which manages diagnostic image access and distribution across the enterprise, as well as ORBIS, Agfa HealthCare’s Hospital and Clinical Information System (HIS/CIS). New customers include a wide range of healthcare providers, from large multi-site facilities and regional care providers, to medium sized facilities and imaging centers.
In North America nearly 40 new agreements were sealed, including with both the Collingwood General & Marine Hospital in Ontario and the Province of Alberta in Canada. In the United States, the company’s IMPAX solutions are being installed at eight Department of Veterans Affairs hospitals, as well as the Cleveland Clinic Foundation, a non-profit 1300 bed academic medical center employing 2000 physicians and scientists and counting 4.2 million patient visits per year. Multiple agreements for the company’s Cardiology solutions were also signed at around ten hospital sites across the United States.
In Asia-Pacific, Agfa HealthCare has signed no less than nine new agreements for the installation of its IMPAX and associated solutions. Leading sites include the National Taiwan University Hospital (NTUH) and its branches, a 2500 bed facility employing nearly 6000 staff members serving some 2.2 million outpatients per year. In Hong Kong, Agfa HealthCare signed agreements with four leading facilities, including the Queen Elizabeth Hospital, Kowloon Hospital, United Christian Hospital and Tseung Kwan O Hospital. Latin America also saw a number of new key customers for its healthcare IT solutions, including the Hospital Mutual de Seguridad in Santiago, Chile and the 25-site FIDI Foundation diagnostic group in Brazil.